Hikma Pharmaceuticals (LON:HIK) Shares Up 7.4% – Here’s Why

Hikma Pharmaceuticals PLC (LON:HIK)’s stock price rose 7.4% during trading on Friday . The stock traded as high as GBX 2,114 ($28.08) and last traded at GBX 2,084 ($27.68). Approximately 937,337 shares traded hands during trading, a decline of 32% from the average daily volume of 1,387,898 shares. The stock had previously closed at GBX 1,941 ($25.78).

Analyst Upgrades and Downgrades

HIK has been the topic of several research analyst reports. JPMorgan Chase & Co. reiterated an “overweight” rating on shares of Hikma Pharmaceuticals in a research note on Friday, March 7th. Berenberg Bank reiterated a “buy” rating and set a GBX 2,560 ($34.01) price target on shares of Hikma Pharmaceuticals in a research note on Monday, March 10th.

Hikma Pharmaceuticals Price Performance

The company’s 50 day moving average is GBX 1,950.89 and its 200 day moving average is GBX 2,016.10. The company has a current ratio of 1.66, a quick ratio of 1.27 and a debt-to-equity ratio of 55.82. The stock has a market capitalization of £5.74 billion, a price-to-earnings ratio of 20.31, a price-to-earnings-growth ratio of 2.38 and a beta of 0.41.

Hikma Pharmaceuticals Increases Dividend

The business also recently declared a dividend, which was paid on Thursday, May 1st. Investors of record on Thursday, March 20th were paid a dividend of $0.48 per share. This is a positive change from Hikma Pharmaceuticals’s previous dividend of $0.32. This represents a yield of 1.8%. The ex-dividend date was Thursday, March 20th. Hikma Pharmaceuticals’s dividend payout ratio (DPR) is currently 60.84%.

Insider Buying and Selling at Hikma Pharmaceuticals

In other Hikma Pharmaceuticals news, insider Victoria Hull sold 2,777 shares of Hikma Pharmaceuticals stock in a transaction on Tuesday, April 8th. The shares were sold at an average price of GBX 1,800 ($23.91), for a total value of £49,986 ($66,400.11). 30.54% of the stock is currently owned by company insiders.

About Hikma Pharmaceuticals

At Hikma we help put better health within reach, every day. By creating high-quality medicines and making them accessible to the people who need them, we help to shape a healthier world that enriches all our communities. We help deliver this by living our culture, delivering our strategy, and acting responsibly.